Our Retts results must be due soon. It will be interesting how they compare with the Neuren/Acadia results.
We know we have limited side effects for our NTI164 in both Pandas Pans and ASD, so I assume we will also have limited side effects for Retts, so only a small improvement in patients should be significant.
Significant Re Rating $80 to $800m, page-12
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.003(5.36%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.5¢ | 5.3¢ | $31.17K | 573.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3007990 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.32pm 05/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |